Epidarex Capital

ActiveBioTech Life Sciences Therapeutics Venture Capital

Website LinkedIn

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Feb 27, 2024	Curve Therapeutics	$51.4M Series A	—	Advent Life Sciences, Ian Connatty, Columbus Venture Partners
Jan 30, 2024	Enterprise Therapeutics	$33.0M Series B	Rob Woodman	Forbion, Novartis, Versant Ventures
Nov 24, 2022	Nyra Medical	$20.0M Series A	Amrinder Singh, Vensana Capital	Broadview Ventures, Georgia Research Alliance
Aug 1, 2022	RapidPulse	$11.0M Series A	Santé Ventures, Syntheon	Broadview Ventures, Hatteras Venture Partners
May 31, 2022	Harness Therapeutics	$5.8M Seed Extension	Mary Canning	Christian Jung
Oct 1, 2021	Leucid Bio	$16.0M Series A	Peter Finan, martin diggle	Soffinova Partners, Heikki Lanckriet, Future Fund
Jul 29, 2021	Topas Therapeutics	$21.3M Series B Extension	—	BioMedPartners, Boehringer Ingelheim, EMBL Ventures, Werner Lanthaler, Gimv, Vesalius Biocapital
Jun 1, 2021	RapidPulse	$15.0M Series A	Saints Capital	Santé Ventures, Broadview Ventures, Hatteras Venture Partners, Sean McBrayer
Jan 1, 2021	Theolytics	$7.0M Series A	Epidarex Capital, Taiho Ventures	M Ventures (Merck)
Sep 1, 2020	Libra Therapeutics	$29.0M Series A	Martin Heidecker, Henning Steinhagen, Saints Capital	AMR Action Fund, Mission BioCapital, Dolby Family Ventures, Sixty Degree Capital, Yonjin Capital
Nov 14, 2019	Lunac Therapeutics	$3.4M Series A	Mary Canning, Andy Duley	—
Aug 29, 2019	Caldan Therapeutics	$1.8M Other Equity	Elizabeth Roper, David Holbrook	—
Jun 1, 2018	NodThera	$40.0M Series A	5AM Ventures, Soffinova Partners	Dave Maki, ARCH Venture Partners, Atlas Venture, Cathay Innovation, Eight Roads Ventures, Firstminute Capital, F-Prime Capital Partners, Frst, Plug & Play Ventures, Polaris Partners, Third Kind Ventures, Elizabeth Roper, F-Prime Capital
Apr 12, 2018	Enterprise Therapeutics	$37.0M Series B	David Morris, MD, Alexander Mayweg	Elizabeth Roper, Geert Jan Mulder
Aug 1, 2017	Apellis Pharmaceuticals	$60.0M Series E	Maha Katabi, PhD, CFA	Sofinnova Investments, Cormorant Asset Management, F-Prime Capital, Morningside Ventures, Vivo Capital
Nov 10, 2016	Enterprise Therapeutics	$5.0M Other Equity	Elizabeth Roper, Rob Woodman	—
Jun 20, 2016	Mironid	$6.3M Series A	Sinclair Dunlop	Adrian Gillespie, University of Strathclyde
Mar 23, 2016	Topas Therapeutics	$15.6M Series A	Epidarex Capital	EMBL Ventures, Evotec, Gimv
Nov 6, 2015	Caldan Therapeutics	$6.7M Series A	Epidarex Capital	Scottish Enterprise
May 19, 2015	Enterprise Therapeutics	$3.7M Series A Extension	Imperial Innovations	—
Apr 13, 2015	Clyde Biosciences	$2.9M Series A	Epidarex Capital	Glasgow University Holdings, Scottish Enterprise
Dec 4, 2014	Sirakoss	$6.3M Grant / Series A	Epidarex Capital	Innovate UK, Scottish Enterprise, Worshipful Company of Armourers & Brasiers
Dec 2, 2014	Apellis Pharmaceuticals	$33.0M Series C	AJU IB Investment, Epidarex Capital, Gerald Chan	—
Sep 10, 2014	Harpoon Medical	$3.2M Series A	Kyparissia Sirinakis	Abell Foundation, Maryland Venture Fund
Feb 8, 2014	Edinburgh Molecular Imaging	$6.6M Series A	—	Scottish Enterprise